AMN Healthcare Services falls after earnings because of mixed margins and revenue drivers

What happened

AMN Healthcare Services (AMN) fell 23.7% on November 6, 2026, because of the results it reported the prior day, as investors digested a mix of revenue growth and weaker margins. Trading volume was 2.0 times its 20-day average as the market reacted to quarterly figures and management commentary. The S&P 500 rose 0.3% on the day, while the healthcare sector median rose 1.9%, leaving AMN 25.6 percentage points worse than its sector median.

How big was the move

The stock closed at $36.19, a decline that was 5.6 times a typical daily move for this stock. It opened 9.6% below the previous close and finished the five-session stretch having fallen 23.2%. Over the same five sessions the S&P 500 fell 2.7%, underscoring that the move was company-specific and tied to the earnings report. The stock’s market value was $1.82 billion on the session.

The technical picture

The stock traded 16.8% below its 20-day moving average and 5.3% below its 50-day moving average, while remaining 24.4% above its 200-day moving average. The 50-day average is above the 200-day average, a sign of an established uptrend, and the stock had spent 144 consecutive trading days above the 200-day average before this week. Its Relative Strength Index (14 days) was 36, in a neutral range, and the stock was 27.1% below its 52-week high. Volatility was 67% annualized over 60 days, higher than 86% of its own readings over five years.

Fundamentals and valuation

For the four quarters through September 30, 2026, the company reported revenue of $3.52 billion, which grew 29.5% from a year earlier. Diluted earnings per share were $2.75 and gross margin was 28.4%, down from 29.4% a year earlier. Operating margin declined to 5.8% from 11.2% a year earlier, while free-cash-flow margin was 9.3% and return on invested capital was 6.4%. The balance sheet showed net debt of 1.4 times EBITDA, and share count over one year increased by 3.8%.

The data show a company still expanding revenue quickly but under pressure on operating profitability. Revenue growth accelerated versus the prior quarter, which recorded growth of 24.0%, yet operating margin roughly halved year over year. That split — strong top-line expansion alongside a weaker operating margin — helps explain why investors sold shares despite strong sales gains.

On valuation, the stock traded at 13.2 times trailing earnings, which is higher than 53% of its own readings over the past five years, where the five-year median is 12.0 times earnings. Price to forward earnings was 11.0 times expected earnings and free-cash-flow yield was 17.9%. PromtFinance scores placed the company at 96 on Value (Exceptional), 72 on Growth (Positive) and 85 on Quality (Strong), with Stability at 41 (Weak). Those scores suggest investors are paying a premium relative to recent history for a company with strong value and quality metrics but weaker stability.

Earnings and analyst expectations

AMN reported third-quarter results on November 5, 2026, that included quarterly revenue of $717 million, adjusted EBITDA of $94 million, GAAP net income of $0.83 per share and adjusted EPS of $1.16. Management said revenue rose driven by greater demand for travel nurses and allied healthcare professionals and a favorable adjustment tied to past labor disruptions, according to Seeking Alpha and Zacks Investment Research. The company’s adjusted EPS of $1.16 was reported as $1.16 against $0.23 expected, 406.1% above estimates, and marked the third consecutive quarter beating estimates. The average surprise over the last four reports was 100.0% above estimates, and the typical two-day reaction after recent reports was the stock rose 0.1%.

Analysts had a consensus price target of $37.75, 4.3% above the closing price, based on ratings from 17 analysts and a consensus rating of Buy. Fifty-nine percent of ratings were Buy or Strong Buy. The next scheduled report date was February 18, 2027.

Taken together, the results showed strong operational demand that lifted revenue, but softer margins that amplified investor sensitivity. The steep intraday drop implies the market will be watching whether margin pressures ease and whether management guidance shifts in coming quarters.

What to watch

• November 5, 2026: reported quarterly revenue of $717 million and adjusted EPS of $1.16, 406.1% above estimates, per Seeking Alpha and Zacks Investment Research
• Four quarters through September 30, 2026: revenue of $3.52 billion, grew 29.5% year over year
• Operating margin: 5.8% for the four quarters through September 30, 2026, versus 11.2% a year earlier
• Price to trailing earnings: 13.2 times trailing earnings; price to forward earnings: 11.0 times expected earnings
• Volatility: 67% annualized over 60 days, higher than 86% of its readings over five years